A leading global partner
To leverage Amador expertise, reputation and business ecosystem to provide global-standard services to biopharmaceutical companies.
ESTABLISHED IN 2018, AMADOR IS COMMITTED TO PROVIDE HIGH-QUALITY, TIMELY AND COST-EFFECTIVE SERVICES TO SUPPORT THE DEVELOPMENT OF NOVEL THERAPEUTICS
Our leadership team members have extensive drug development experience at leading biopharmaceutical companies or global CROs. Our AWS-based computer system and software are fully validated. With an implemented QMS, Amador has passed multiple qualification and audits without major findings.
As of July 2021, Amador has supported 6 successful BLA/NDA submissions for US, EU, China and MNC clients, providing services in clinical pharmacology, pharmacometrics, immunogenicity, SAS programming, project management and medical writing.